Cystic fibrosis is the most common inherited disease in the
Introduction
Small fragment homologous replacement (SFHR)-mediated targeting has been shown to specifically modify genomic DNA with small DNA fragments (SDF). 1, 2 SFHR-mediated targeting was developed and successfully used in vitro and in vivo to modify the ⌬F508 locus of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. [3] [4] [5] More recently SFHR was employed to cause a nonsense transition in the dystrophin gene (dys) of the mdx mouse. 6 Recently, the conditions for the in vitro delivery of small fragments via the Gene Porter cationic liposomes, were evaluated. 5 A CF cell line, CFBE41o Ϫ , homozygous for the ̅F508 mutation showed an increase in conversion to wild-type (wt) sequences after transfection with wt-CFTR SDF when lipid/DNA ratio was 6(+):1(Ϫ). 5 Although all these studies are encouraging with regard to the possible therapeutic application of SFHR, long-term SFHR-mediated modification of genomic DNA in a clonal population remains to be demonstrated. One study showed a disappearance of in vitro correction after 30 days. 5 This was apparently due to a reduction in the proportion of corrected cells as a function of time, resulting in a decrease in the PCR signal used as an indicator of SFHR-mediated targeting. Although the mechanism underlying this dilution of SFHR-modified cells is unknown, it is clear from allelespecific PCR analysis that a subpopulation of SFHRmodified cells is present for extended periods. To demonstrate the stability of SFHR-mediated modification of genomic DNA and to evaluate the sensitivity of various ana- lytical approaches, studies were undertaken to isolate a population of cells that maintained high levels of SFHRmediated modification over multiple generations. Five isogenic cell lines derived from CFBE41o
Ϫ cells transfected with wt-CFTR SDF were isolated and analyzed.
Results
Transfected CF airway epithelial cells (CFBE41o Ϫ ) were subcloned by limiting dilution (Figure 1) . A total of 30 single clones were isolated and expanded. Genomic fingerprint analysis was undertaken to characterize the isogenic nature of the cell lines. Four short tandem repeats (STR) that map to chromosomes 5, 11, 2 and 12 were characterized (Figure 2, columns A-D) . The fingerprint patterns of the cell lines were identical to those of the parental CFBE41o Ϫ cells. The DNA profile observed is consistent with the notion that the isolated cell lines are isogenic and are derived from the parental CFBE41o Ϫ cells. The presence of the wt SFHR-modified allele was characterized by allele-specific PCR amplification (ASP) and by non allele-specific amplification (NASP) of isolated DNA. The wt allele was detected in five isogenic cell lines (Figure 3, lanes 1-5, cell lines A, L, F, O and Q). The unequal signal intensity between the wt and the mutant allele suggested that not all the endogenous ̅F508 CFTR alleles were corrected. This result is not unexpected in that there may be more than two alleles given the aneuploid nature of transformed cell lines. Verification that genomic correction resulted in synthesis of wt-CFTR mRNA was determined by non-allele specific PCR amplification of mRNA-derived cDNA (Figure 4) . The analysis indicates that cell lines F and Q (lines 5, 7), expressed both the wt-and ̅F508-CFTR alleles. The cell
Figure 2 Genomic fingerprint analysis. Isogenic cell lines were genotyped by Gene Print Fluorescent STR Systems (Promega, Madison, WI, USA), according to the manufacturer's instructions. The test is based on the haplotypes resulting from the segregation of four short tandem repeats (STR): (column A) human c-fms proto-oncogene (CSF1PO, 5q33.3-34), (column B) human tyrosine hydroxylase gene (TH01, 11p15.5), (column C) human tyroid peroxidase gene (TPOX, 2p25.1-pter) and (column D) human von Willebrand factor gene (vWA, 12p12-pter). Genomic fingerprints of three SFHR-modified CFBE41o
Ϫ
-derived isogenic cell lines are indicated. The patterns of these three cell lines (rows 1, 2 and 3) are identical to the parental CFBE41o Ϫ cell line (row 4), suggesting that the cell lines are isogenic and derived from the CFBE41o
Ϫ cells. 
Discussion
The potential of SFHR-mediated targeting for modification of the CFTR exon 10 sequences involved in the ̅F508 3-bp deletion was previously demonstrated both in vitro than in vivo. [3] [4] [5] 8 The present study focuses on the isolation of cells in which the endogenous CFTR gene has been modified in vitro by SFHR. The results indicate that SFHR is able to stably correct the ̅F508-CFTR mutation and that SFHR-generated isogenic cell lines can be maintained in culture up to 150 generations without any apparent change in their genotype.
The ultimate establishment of isogenic, SFHR-modified cell lines is an important step in elucidating how genetic background can influence CF phenotype/pathology.
By eliminating inter-individual variability due to genetic background, it will be possible to develop a better understanding of how individual mutations affect CFTR function.
The variability in wt-CFTR mRNA levels among the 
